Creganna-Tactx reprices first-lien term loan to Libor plus 375 bps

By Sara Rosenberg

New York, May 21 – Creganna-Tactx Medical wrapped a repricing of its first-lien term loan (B1/B) due Dec. 1, 2021 to Libor plus 375 basis points with a 1% Libor floor from Libor plus 425 bps with a 1% Libor floor, according to a market source.

The repriced loan has 101 soft call protection for six months and a par issue price, the source said.

RBC Capital Markets, Morgan Stanley Senior Funding Inc., Bank of Ireland and Societe Generale are the lead banks on the deal.

Creganna-Tactx is a Galway, Ireland-based provider of medical device outsourcing services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.